2025.07

AlzMed Inc. to Present Novel ELISA “Syncheck™” for Memory Function Monitoring at the 48th Annual Meeting of the Japan Neuroscience Society (July 25, 2P-369).

2025.04

Our CSO, Yuko Sekino (Project Professor at the University of Tokyo), will speak at CPHI Japan (Tokyo Big Sight) on “A Japan-Driven Breakthrough in MCI Treatment: Drebrin Drug Discovery from Memory Research.

2025.03

The Funakoshi website has been updated with new details on the anti-drebrin antibody, M2F6-Shirao.

2025.03

Our diagnostic project has been selected for AMED’s FY2025 Medical Device Development Promotion Research Program.

2025.01

We exhibited a booth at Japan Night held in San Francisco on January 13, 2025.

2024.11

AlzMed Products Now Available through Funakoshi – Featuring Drebrin Antibody and Frozen Rat Primary Hippocampal Neurons

2024.01

Our patent for an animal model of Alzheimer’s disease has been registered.

2023.08

Our patent on drdrebrin-binding peptide was registered.

2023.03

Our patent for a diagnostic agent has been registered.

2023.08

We have been selected for the Tokyo Metropolitan Small and Medium Enterprise Promotion Agency’s startup intellectual property support program.